Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00318058 | Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population | PHASE1 | COMPLETED | 84 | — | — | Oct 3, 2005 | Nov 4, 2005 | May 8, 2017 | 1 | Belgium |
| Name | Type | Description |
|---|---|---|
| influenza vaccine Fluarix, Adjuvanted Fluarix | BIOLOGICAL | - |
Inclusion Criteria: * A male or female aged over 65 years at the time of the revaccination; who previously received the adjuvanted candidate vaccine or Fluarix during a clinical study organized during the preceeding year Exclusion Criteria: * Use of any investigational or non-registered product (...